SINGAPORE - Researchers from the National Neuroscience Institute (NNI) are embarking on a ground-breaking project to transplant stem cells into the brains of those with early Parkinson’s disease ...

Landmark trials using stem cells to treat Parkinson’s disease in the USA and Japan mark a turning point for ... Her team is preparing a phase 2 trial of fetal neural-cell transplantation, ...

Dopaminergic cell transplantation may provide new hope for Parkinson's sufferers--if a suitable long-term source of transplantable dopaminergic neurons can be found.

A new study reveals that transplanting healthy human glial progenitor cells into adult mice with Huntington’s disease can delay motor and cognitive decline and extend lifespan.

Introduction A major driver of the global autologous cell therapy market is the rising demand for personalized and precision-based medical trea ...

Keeping a healthy mix of friendly microbes in the gut—known as eubiosis—is crucial for good health. When that delicate ...

Bemdaneprocel is administered by surgical transplantation into a part of the brain ... The results put BlueRock among the leaders in the quest to develop stem cell-based therapies for Parkinson's.

Bayer subsidiary BlueRock Therapeutics has been granted a fast-track review by the FDA for DA01, its stem cell-based therapy for Parkinson's disease which is currently in early-stage clinical testing.

Global Cell Cryopreservation Medium Market is forecast to witness a rise in revenue from US$ $$ Million in 2022 to USD $$ Million by 2031, growing at a CAGR of % during the forecast period from 2023 ...

They found that faecal transplants often led to regional mismatches – the wrong microbes ending up in the wrong place. This ...

Four Indiana research universities — IU, Purdue, Notre Dame and Ball State — stand to lose $68 million in National Institutes ...